Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ann Mary Gray

Affiliations

  • Director at Sarepta Therapeutics Inc. (SRPT), 2019-12-11
  • Director at Rapt Therapeutics Inc. (RAPT), 2019-12-06
  • Director at Neuralstem Inc. (CUR), 2019-10-11
  • Director at Senomyx Inc (SNMX), 2018-11-02
  • Director at Juniper Pharmaceuticals Inc (JNP), 2018-08-15
  • Director at Galena Biopharma Inc. (GALE), 2017-10-10
  • at Acadia Pharmaceuticals Inc (ACAD), 2016-06-09
  • Other at Dyax Corp (DYAX), 2016-01-22
  • Director at Tetralogic Pharmaceuticals Corp (TLOG), 2015-01-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SNMX $1.00 10,000 Director 10,000 2017-03-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACAD $35.00 4,250 0 2015-01-13 Filing
ACAD $31.74 12,250 0 2014-12-15 Filing
ACAD $20.71 10,000 0 2013-08-26 Filing
ACAD $20.62 5,000 10,000 2013-08-26 Filing